Table 1.
Groups | n | LATS2-AS1-001 expression | P | |
---|---|---|---|---|
High | Low | |||
Gender | 0.646 | |||
Male | 267 | 81 | 186 | |
Female | 90 | 25 | 65 | |
Age (year) | 0.220 | |||
≥60 | 202 | 59 | 143 | |
< 60 | 155 | 47 | 108 | |
Tumor size | 0.167 | |||
≥ 5 | 252 | 70 | 182 | |
< 5 | 105 | 36 | 69 | |
Borrmann’s types | 0.394 | |||
Bor.I + II | 30 | 11 | 19 | |
Bor.III + IV | 327 | 95 | 230 | |
WHO’s histological types | 0.448 | |||
Papillary adenocarcinoma | 6 | 3 | 3 | |
Tubular adenocarcinoma | ||||
Well differentiated | 10 | 2 | 8 | |
Moderately differentiated | 80 | 25 | 55 | |
Poorly differentiated | 219 | 67 | 152 | |
Signet ring cell adenocarcinoma | 27 | 6 | 21 | |
Mucinous adenocarcinoma | 15 | 3 | 12 | |
Lauren’s types | 0.905 | |||
Intestinal | 96 | 30 | 66 | |
Diffuse | 180 | 55 | 125 | |
Mixed | 81 | 21 | 60 | |
Depth of invasion | 0.568 | |||
T1 + 2 | 26 | 9 | 17 | |
T3 + 4 | 331 | 97 | 234 | |
Lymph node metastasis | 0.282 | |||
N0 | 78 | 27 | 51 | |
N1–3 | 279 | 79 | 200 | |
Distant metastasis | 0.968 | |||
M0 | 345 | 103 | 242 | |
M1 | 12 | 3 | 9 | |
TNM staging | 0.032 | |||
I + II | 100 | 38 | 62 | |
III + IV | 257 | 68 | 189 |
Significance of P < 0.05 is indicated in italic